Skip to main content
Log in

Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels

  • Letter to the editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Igerc I, Kohlfurst S, Gallowitsch HJ, et al. The value of 18F-Choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35(5):976–983; DOI 10.1007/s00259-007-0686-9.

  2. Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol. 2005;173(1):252–5.

    PubMed  Google Scholar 

  3. Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006;47(2):262–9.

    PubMed  Google Scholar 

  4. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000;164(2):400–4.

    Article  PubMed  CAS  Google Scholar 

  5. Rietbergen JB, Kruger AE, Hoedemaeker RF, Bangma CH, Kirkels WJ, Schroder FH. Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer. J Urol. 1998;160(6 Pt 1):2121–5.

    PubMed  CAS  Google Scholar 

  6. DeGrado TR, Coleman RE, Wang S, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61(1):110–7.

    PubMed  CAS  Google Scholar 

  7. Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168(1):273–80.

    Article  PubMed  Google Scholar 

  8. Bansal A, Shuyan W, Hara T, Harris RA, DeGrado TR. Biodisposition and metabolism of [18F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats. Eur J Nucl Med Mol Imaging 2008; 35(6):1192–1203; DOI 10.1007/s00259-008-0736-y.

    Google Scholar 

  9. Aoki Y, Arai Y, Maeda H, Okubo K, Shinohara K. Racial differences in cellular composition of benign prostatic hyperplasia. Prostate 2001;49(4):243–50.

    Article  PubMed  CAS  Google Scholar 

  10. Hoke G, Baker W, Barnswell C, et al. Racial differences in pathogenetic mechanisms, prevalence, and progression of benign prostatic hyperplasia. Urology 2006;68(5):924–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandi A. Kwee.

Additional information

An author’s reply to this letter is available at http://dx.doi.org/10.1007/s00259-008-0783-4.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kwee, S.A., DeGrado, T. Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels. Eur J Nucl Med Mol Imaging 35, 1567–1569 (2008). https://doi.org/10.1007/s00259-008-0781-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-0781-6

Keywords

Navigation